AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pharmaceutical Companies

785.616

-7.434-0.94%

Number of Gainers:6

Number of Losers:21

Number of Flat:19

PE:- -

High:793.095

Open:793.093

Low:782.162

Close:793.051

Loading ...

Sol-Gel- Sgt-610 Phase Iii Trial Top-Line Results Expected Q4 2026

THOMSON REUTERS

Federal Reserve Chair Powell Suggests Easing Bank Cryptocurrency Rules

Here are the top 10 ASX 200 shares today

Mesoblast Expands Insurance Coverage for Ryoncil to 104 Million Lives in US

MT Newswires Live

Prescient Therapeutics Receives Fast Track FDA Designation for Potential Lymphoma Treatment; Shares Up 5%

MT Newswires Live

Why Imricor, Nanosonics, Perpetual, and Tourism Holdings shares are sinking today

Imricor Receives CE Mark Approval for Electrophysiology Recording, Cardiac Simulator System; Shares Fall 4%

MT Newswires Live

3 ASX Growth Companies With Up To 23% Insider Ownership

Simply Wall St.

BUZZ-Australia's Prescient Therapeutics gains on FDA fast-track status for cancer drug

Proteomics International Laboratories Ltd - Seeks Trading Halt Pending Announcement on Capital Raise

THOMSON REUTERS

Batik Air Passenger Ejected Following Bomb Joke

BRIEF-Prescient Therapeutics' PTX-100 Receives U.S. FDA Fast Track Designation

Prescient Therapeutics Ltd - Ptx-100 Receives U.S. FDA Fast Track Designation

THOMSON REUTERS

What percentage of US CEOs expect a recession within 6 months?

ASX April 2025: Highlighting Three Stocks That May Be Trading Below Estimated Value

Simply Wall St.

3 of the best ASX 200 healthcare shares to bring your portfolio to life

AnteoTech Appoints Interim CEO

MT Newswires Live

Anteotech Ltd - David Radford Steps Down as CEO

THOMSON REUTERS

Anteotech - Appoints Merrill Gray as Interim CEO and Managing Director

THOMSON REUTERS

CSL, Resmed Are Morgan Stanley's Australia Healthcare Picks in the Tariff Era -- Market Talk

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK7508/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":785.6164,"timestamp":1745295178313,"preClose":793.05054,"halted":0,"volume":54297523,"delay":0,"changeRate":-0.009374,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-7.434143,"latestTime":"04-22 14:13:04 AEST","open":793.0932,"high":793.0951,"low":782.16187,"amount":265627514,"amplitude":0.013786,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745301600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745280000000,1745301600000]],"turnoverRate":0.001472,"increases":7,"decrements":20,"flats":16,"marketCap":124076295649.875,"floatMarketCap":121583478028},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":793.0951,"amplitude":0.013786,"preClose":793.05054,"low":782.16187,"latestPrice":785.6164,"volume":54297523,"delay":0,"open":793.0932,"prevYearClose":936.801,"prevWeekClose":793.051,"prevMonthClose":815.605,"prevQuarterClose":815.605,"fiveDayClose":769.762,"twentyDayClose":833.755,"sixtyDayClose":904.08,"secType":"PLATE","market":"AU","turnoverRate":0.001472,"marketCap":124076295649.875,"floatMarketCap":121583478028,"timestamp":1745295178313,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":6,"down":21,"flat":19},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528149007","title":"Sol-Gel- Sgt-610 Phase Iii Trial Top-Line Results Expected Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2528149007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528149007?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:42","pubTimestamp":1744893775,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV1FQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","BK4007","MYX.AU","SLGL"],"gpt_icon":0},{"id":"2528676497","title":"Federal Reserve Chair Powell Suggests Easing Bank Cryptocurrency Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2528676497","media":"Blockbeats","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528676497?lang=en_us&edition=fundamental","pubTime":"2025-04-17 16:21","pubTimestamp":1744878060,"startTime":"0","endTime":"0","summary":"BlockBeats News, April 17th, according to TechinAsia report, this morning Federal Reserve Chairman Powell stated during an interview at the Chicago Economic Club that in the future, regulatory restric","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/290122","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["OCC.AU","US12M.BOND","BK4096","US3Y.BOND","US2Y.BOND","BK4588","US5Y.BOND","BK4585","US30Y.BOND","US10Y.BOND","APT.USD.HKCC","US6M.BOND","US7Y.BOND","OCC","BK7067","BK4020","BK7508","TON.USD.CC","TON.USD.HKCC","APT.USD.CC"],"gpt_icon":0},{"id":"2528786795","title":"Here are the top 10 ASX 200 shares today","url":"https://stock-news.laohu8.com/highlight/detail?id=2528786795","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528786795?lang=en_us&edition=fundamental","pubTime":"2025-04-17 15:04","pubTimestamp":1744873451,"startTime":"0","endTime":"0","summary":"The S&P/ASX 200 Index (ASX: XJO) enjoyed a positive end to this short trading week today. After a volatile week, investors were clearly in a good mood this Thursday, sending the ASX 200 up 0.78%. That","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/17/here-are-the-top-10-asx-200-shares-today-17-april-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7507","BK7129","CGF.AU","LYC.AU","CU6.AU","BK7096","ALD.AU","BK7065","BK7506","BK7112","IGO.AU","BK7139","BOQ.AU","SMR.AU","ILU.AU","BK7083","KAR.AU","BK7126","BK7095","PNV.AU","BK7142","BK7508","BK7504","XJO.AU"],"gpt_icon":0},{"id":"2528732243","title":"Mesoblast Expands Insurance Coverage for Ryoncil to 104 Million Lives in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2528732243","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528732243?lang=en_us&edition=fundamental","pubTime":"2025-04-17 12:23","pubTimestamp":1744863798,"startTime":"0","endTime":"0","summary":"Mesoblast  expanded its coverage for Ryoncil to 104 million US government- and private-insured lives, according to a Thursday filing with the Australian bourse.Ryoncil is approved by the US Food and Drug Administration for mesenchymal stromal cell therapy.It is the only approved therapy for steroid-refractory acute graft versus host disease  in children aged two months and older, a separate filing showed.Mesoblast's shares were up nearly 2% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","MESO","MSB.AU","BK7067","BK7501","BK4139"],"gpt_icon":0},{"id":"2528329537","title":"Prescient Therapeutics Receives Fast Track FDA Designation for Potential Lymphoma Treatment; Shares Up 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528329537","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528329537?lang=en_us&edition=fundamental","pubTime":"2025-04-17 12:18","pubTimestamp":1744863516,"startTime":"0","endTime":"0","summary":"Prescient Therapeutics  received a fast-track designation from the US Food and Drug Administration for its PTX-100 compound for the potential treatment of adults with relapsed or refractory mycosis fungoides, according to a Wednesday filing with the Australian bourse.The designation will expedite the review of therapies for serious conditions with high unmet need, enabling earlier delivery to patients, the filing said.Mycosis fungoides is a subtype of cutaneous T-cell lymphoma, a group of rare blood cancers affecting the skin.Shares rose nearly 5% in afternoon trade Thursday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BYQQ9H92.USD","BK4139","FAST","LENZ","BK4585","BK7067","BK4007","IE00BFXG0V08.USD","BK4567","PTX.AU","IE00B5TLWC47.USD","BK4588","BK4104","BK7508"],"gpt_icon":0},{"id":"2528573084","title":"Why Imricor, Nanosonics, Perpetual, and Tourism Holdings shares are sinking today","url":"https://stock-news.laohu8.com/highlight/detail?id=2528573084","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528573084?lang=en_us&edition=fundamental","pubTime":"2025-04-17 12:04","pubTimestamp":1744862698,"startTime":"0","endTime":"0","summary":"In afternoon trade, theS&P/ASX 200 Index (ASX: XJO) is on course to record a decent gain. At the time of writing, the benchmark index is up 0.6% to 7,803.9 points. Four ASX shares that have failed to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/17/why-imricor-nanosonics-perpetual-and-tourism-holdings-shares-are-sinking-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["XJO.AU","BK7126","MDR.AU","BK7508","PPT.AU","BK7125","BK7007","BK7094","BK7161","NAN.AU","IMR.AU","BK7062","THL.AU","BK7503"],"gpt_icon":0},{"id":"2528355757","title":"Imricor Receives CE Mark Approval for Electrophysiology Recording, Cardiac Simulator System; Shares Fall 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528355757","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528355757?lang=en_us&edition=fundamental","pubTime":"2025-04-17 10:51","pubTimestamp":1744858297,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said that its Advantage-MR electrophysiology recording and cardiac stimulator system received CE mark certification under the European Union's new medical device regulations regime, according to a Thursday Australian bourse filing.The commercial launch of its second-generation Vision-MR ablation catheter and the new Advantage-MR system is planned to start in June across new and existing sites in the EU.In February, the company's second-generation Vision-MR ablation catheter received CE mark approval under the medical device regulations regime.Imricor's shares fell almost 4% in recent trading on Thursday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","IMR.AU","BK4585","BK4109","BK7508","BK7503","CE","BK7007"],"gpt_icon":0},{"id":"2528272737","title":"3 ASX Growth Companies With Up To 23% Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2528272737","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528272737?lang=en_us&edition=fundamental","pubTime":"2025-04-17 03:38","pubTimestamp":1744832288,"startTime":"0","endTime":"0","summary":"As the Australian market navigates a period of slower trade and investor caution amid ongoing global tensions, identifying growth companies with significant insider ownership can offer valuable insights into potential investment opportunities. In this environment, where confidence is tempered by geopolitical uncertainties, stocks with strong insider commitment may signal a higher level of trust in the company's long-term prospects.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 93 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Overview: Aurelia Metals Limited is an Australian company involved in the exploration and production of mineral properties, with a market capitalization of A$456.99 million.Operations: The company's revenue is primarily derived from its operations at the Peak Mine , Dargues Mine , and Hera Mine .Clarity Pharmaceuticals demonstrates strong growth potential, driven by its innovati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-asx-growth-companies-23-193808763.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["CU6.AU","PLT.AU","BK7116","BK7506","CYC.AU","EIQ.AU","IPX.AU","IMA.AU","XAO.AU","AMI.AU","AAL.AU","BK7096","FEX.AU","TTT.AU","BK7007","BBT.AU","XJO.AU","BK7093","NWF.AU","ACR.AU","BK7508","XKO.AU","BK7016","BK7036","IPX","BK7095","BK7077","BK7078","BK7129"],"gpt_icon":0},{"id":"2527401260","title":"BUZZ-Australia's Prescient Therapeutics gains on FDA fast-track status for cancer drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2527401260","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527401260?lang=en_us&edition=fundamental","pubTime":"2025-04-16 09:35","pubTimestamp":1744767341,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Prescient Therapeutics gains on FDA fast-track status for cancer drug** Shares of Prescient Therapeutics PTX.AX rise as much as 28.6% to A$0.054, hit their highest levels since February 11** The clinical-stage oncology co says it received the US FDA Fast-Track designation for PTX-100, a treatment for adults with relapsed or refractory mycosis fungoides** PTX-100 is a compound with the ability to block an important cancer growth enzyme, says co** The fast-track status is an important step towards commercialisation of the drug, says co** About 2.7 million shares change hands, 4.3 times the 30-day average volume of shares** Stock down 16% this year, as of last close  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nL4N3QU034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTX.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2527405917","title":"Proteomics International Laboratories Ltd - Seeks Trading Halt Pending Announcement on Capital Raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2527405917","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527405917?lang=en_us&edition=fundamental","pubTime":"2025-04-16 08:57","pubTimestamp":1744765044,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QT2HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","PIQ.AU","BK7508"],"gpt_icon":0},{"id":"2527240411","title":"Batik Air Passenger Ejected Following Bomb Joke","url":"https://stock-news.laohu8.com/highlight/detail?id=2527240411","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527240411?lang=en_us&edition=fundamental","pubTime":"2025-04-16 08:46","pubTimestamp":1744764410,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Tangerang - A female passenger was banned from flying and forcibly removed from the aircraft after claiming to have a bomb on a Batik Air flight Soekarno-Hatta Airport - Manado.\"The guest was not allowed to continue the flight, and was taken off the plane to be handed over to the relevant authorities,\" said Corporate Communications Strategic of Batik Air Danang Mandala Prihantoro in a written statement on Wednesday, April 16, 2025.Danang explained that the incident occurred before the departure of flight ID-6272 from Soekarno-Hatta International Airport, Tangerang , to Sam Ratulangi International Airport, Manado  on Tuesday, April 15, 2025.","market":"other","thumbnail":"https://statik.tempo.co/data/2020/02/06/id_912718/912718_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2020/02/06/id_912718/912718_720.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/1997259/batik-air-passenger-ejected-following-bomb-joke","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK7502","AIRI","SOP","MDC.AU","BK7067","BK7508","BK4187","BK7050","SOP.AU"],"gpt_icon":0},{"id":"2527547722","title":"BRIEF-Prescient Therapeutics' PTX-100 Receives U.S. FDA Fast Track Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2527547722","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527547722?lang=en_us&edition=fundamental","pubTime":"2025-04-16 08:00","pubTimestamp":1744761636,"startTime":"0","endTime":"0","summary":"BRIEF-Prescient Therapeutics' PTX-100 Receives U.S. FDA Fast Track DesignationApril 16 (Reuters) - Prescient Therapeutics Ltd PTX.AX:PTX-100 RECEIVES U.S. FDA FAST TRACK DESIGNATIONFurther company coverage: PTX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QT2HJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTX.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2527547420","title":"Prescient Therapeutics Ltd - Ptx-100 Receives U.S. FDA Fast Track Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2527547420","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527547420?lang=en_us&edition=fundamental","pubTime":"2025-04-16 07:20","pubTimestamp":1744759230,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT2HJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTX.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2527717403","title":"What percentage of US CEOs expect a recession within 6 months?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527717403","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527717403?lang=en_us&edition=fundamental","pubTime":"2025-04-16 06:44","pubTimestamp":1744757082,"startTime":"0","endTime":"0","summary":"According to a Chief Executive survey of more than 300 CEOs released on Monday, 62% said they forecasted a recession or other economic downturn in the next six months. The monthly survey reveals an index based on CEOs' rating of current business conditions and future outlook. According to the Chief Executive, it is now at its lowest level since November 2012. Tariff turmoil According to the survey, President Donald Trump's global tariff regime was a major factor in their negative outlook. Of the respondents, 67% said they do not approve of the tariffs, and 76% said they would negatively or very negatively impact their businesses this year. Mitchell Metal Products President and CEO Tim Zimmerman said :  Tariffs and the uncertainty of next steps that will be taken by President Trump will lead to very difficult economic times over the next year or two.  What does a recession look like?Whilst the survey focussed on the US economy, it is relevant for Australian investors because the S&P/ASX","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/16/what-percentage-of-us-ceos-expect-a-recession-within-6-months/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4550","OEX","USAW.SI","BK7501","XKO.AU","IVV","BK4559","TQQQ","BK7042","MNQmain","BK7067","BK7508","BK7511","CSL.AU","BK4534","SSO","NQmain","BK4585","USJW.SI","BK4504","QID","SDS",".IXIC","ESmain","XJO.AU","ARMR.AU","QLD","BK4588","TSYW.SI","PSQ","NVIW.SI","XAO.AU","OEF","SH","SQQQ","VOO","SPY","BK4581",".SPX","ARM.AU","TLS.AU"],"gpt_icon":1},{"id":"2527422174","title":"ASX April 2025: Highlighting Three Stocks That May Be Trading Below Estimated Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2527422174","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527422174?lang=en_us&edition=fundamental","pubTime":"2025-04-16 03:34","pubTimestamp":1744745665,"startTime":"0","endTime":"0","summary":"The Australian market has experienced a relatively stable day, with the ASX200 closing at 7,760 points and sectors such as Health Care showing positive movement while others like Staples lagged. In this context of fluctuating sector performances and strategic shifts among companies, identifying stocks that may be trading below their estimated value can present potential opportunities for investors looking to capitalize on market inefficiencies.Top 10 Undervalued Stocks Based On Cash Flows In Australia. Here we highlight a subset of our preferred stocks from the screener.Overview: Corporate Travel Management Limited is a travel management solutions company that oversees the procurement and delivery of travel services across Australia and New Zealand, North America, Asia, and Europe, with a market cap of A$1.77 billion.Unlock comprehensive insights into our analysis of Corporate Travel Management stock in this financial health report.Overview: Nick Scali Limited, with a market cap of A$1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-april-2025-highlighting-three-193425216.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7096","GSS.AU","NXL.AU","BK7031","BK7117","GNP.AU","XKO.AU","XJO.AU","3DA.AU","BK7115","XAO.AU","SHV.AU","BK7048","MVP.AU","BK7016","ACF.AU","BK7124","EOS.AU","BK7107","BK7088","BK7505","PNR.AU","BK7070","BK7508","BK7501","BK7055","BK7104","PNRDA.AU","NCK.AU","IDX.AU","CTD.AU"],"gpt_icon":0},{"id":"2527447668","title":"3 of the best ASX 200 healthcare shares to bring your portfolio to life","url":"https://stock-news.laohu8.com/highlight/detail?id=2527447668","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527447668?lang=en_us&edition=fundamental","pubTime":"2025-04-16 02:00","pubTimestamp":1744740000,"startTime":"0","endTime":"0","summary":"If your portfolio needs a health check, then the healthcare sector could be just what the doctor ordered. ASX 200 healthcare shares have a history of delivering strong, long-term returns thanks to con","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/16/3-of-the-best-asx-200-healthcare-shares-to-bring-your-portfolio-to-life/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU2471134523.USD","LU2471134952.CNY","LU2471134796.USD","LU1868836914.USD","BK7508","BK4552","IE0002270589.USD","BK7067","IE00BFXG1179.USD","IE0004091025.USD","RMD.AU","LU0048573561.USD","LU2237443622.USD","LU2750360997.AUD","LU2237443978.SGD","BK4127","BK4516","BK7501","PME.AU","BK7094","LU1791807156.HKD","LU1868836757.USD","LU2750360641.GBP","LU1868837136.USD","LU0742534661.SGD","BK7007","LU2471134879.HKD","BK4550","LU0061475181.USD","BK7511","LU2237443549.SGD","IE00B19Z3581.USD","LU2237443895.HKD","CSL.AU","IE00B19Z3B42.SGD","BK4585","LU1868836591.USD","LU1868837300.USD","BK4533","LU2237443465.HKD","IE0034235188.USD","LU2237438978.USD","BK4504","LU0251142724.SGD","BK4588","LU0106831901.USD","IE00BSNM7G36.USD","LU1668664300.SGD","IE0004086264.USD","LU2237443382.USD"],"gpt_icon":0},{"id":"2527675431","title":"AnteoTech Appoints Interim CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2527675431","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527675431?lang=en_us&edition=fundamental","pubTime":"2025-04-15 13:42","pubTimestamp":1744695763,"startTime":"0","endTime":"0","summary":"AnteoTech  appointed Merrill Gray as interim Chief Executive Officer and Managing Director, effective April 16, according to a Tuesday filing with the Australian bourse.Gray will succeed David Radord who is stepping down on Tuesday but will continue to serve as strategic advisor for the next four weeks, the filing said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADO.AU","XKO.AU","XAO.AU","XJO.AU","BK7501","BK7048","BK7036","BK7508"],"gpt_icon":0},{"id":"2527433231","title":"Anteotech Ltd - David Radford Steps Down as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2527433231","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527433231?lang=en_us&edition=fundamental","pubTime":"2025-04-15 12:55","pubTimestamp":1744692947,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QS27B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADO.AU","BK7501","BK7048","BK7036","BK7508"],"gpt_icon":0},{"id":"2527230433","title":"Anteotech - Appoints Merrill Gray as Interim CEO and Managing Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2527230433","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527230433?lang=en_us&edition=fundamental","pubTime":"2025-04-15 12:55","pubTimestamp":1744692947,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QS27B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7036","BK7508","BK7501","ADO.AU","BK7048"],"gpt_icon":0},{"id":"2527481820","title":"CSL, Resmed Are Morgan Stanley's Australia Healthcare Picks in the Tariff Era -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2527481820","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527481820?lang=en_us&edition=fundamental","pubTime":"2025-04-15 11:51","pubTimestamp":1744689060,"startTime":"0","endTime":"0","summary":"0351 GMT - Biopharmaceutical company CSL and medical equipment firm Resmed have the best combination of attractive valuation and low tariff impact among Australian healthcare stocks, suggests Morgan Stanley equity analyst David L. Bailey. He estimates that CSL would need to raise prices by 1% and Resmed would need to raise prices by 2%-3% to offset the earnings impact from tariffs. But given their solid earnings per share growth, low earnings risk and valuation appeal, he says these companies are the \"most favorably positioned\" among peers. One word of caution--pharmaceuticals are currently excluded from reciprocal tariffs, but Trump has signaled he wants to put tariffs on that sector soon, which could impact CSL. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106831901.USD","LU0314104364.USD","LU0971096721.USD","LU1720051017.SGD","BK7508","LU2023251221.USD","LU1668664300.SGD","BK4548","RMD","LU1169590202.USD","BK4567","SGXZ23171101.USD","LU1989772840.SGD","LU0795875086.SGD","CSL","LU2347655156.SGD","LU1548497426.USD","LU1363072403.SGD","LU1732800096.USD","BK4137","BK4581","HCSG","LU0795875169.SGD","BK4534","BK4588","LU2271345857.HKD","CSL.AU","BK4127","BK7511","BK7501","LU0225283273.USD","LU2089284900.SGD","LU0158827781.USD","LU0320765646.SGD","BK4516","LU1074936037.SGD","LU0912757837.SGD","RMD.AU","LU1720051108.HKD","LU0170899867.USD","LU2089283258.USD","MS","LU1162221912.USD","LU2177674079.SGD","LU0158827948.USD","LU0728928796.USD","BK4086","BK4082","LU0098860793.USD","SG9999004303.SGD"],"gpt_icon":1}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":129,"code":"91000000","status":"200"}]}}